• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Risk Factors for Weaning Failure in COVID-19 Patients.新型冠状病毒肺炎患者撤机失败的危险因素
J Crit Care Med (Targu Mures). 2023 Jul 31;9(3):170-177. doi: 10.2478/jccm-2023-0021. eCollection 2023 Jul.
2
Impact of intravenous lidocaine on clinical outcomes of patients with ARDS during COVID-19 pandemia (LidoCovid): A structured summary of a study protocol for a randomised controlled trial.静脉注射利多卡因对 COVID-19 大流行期间 ARDS 患者临床结局的影响(LidoCovid):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Feb 11;22(1):131. doi: 10.1186/s13063-021-05095-x.
3
A randomised, double-blind, placebo-controlled, pilot trial of intravenous plasma purified alpha-1 antitrypsin for SARS-CoV-2-induced Acute Respiratory Distress Syndrome: a structured summary of a study protocol for a randomised, controlled trial.静脉注射血浆纯化的α-1 抗胰蛋白酶治疗 SARS-CoV-2 诱导的急性呼吸窘迫综合征的随机、双盲、安慰剂对照、初步临床试验:一项随机对照试验研究方案的结构化总结。
Trials. 2021 Apr 19;22(1):288. doi: 10.1186/s13063-021-05254-0.
4
Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial.地塞米松治疗 ARDS 合并 COVID-19 患者的效果 - 一项前瞻性、多中心、开放标签、平行组、随机对照试验(REMED 试验):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Mar 1;22(1):172. doi: 10.1186/s13063-021-05116-9.
5
[Weaning from prolonged mechanical ventilation on a specialised weaning unit: a retrospective comparison of patients with and without SARS-CoV-2 infection].[在专业撤机单元上从长期机械通气撤机:感染和未感染SARS-CoV-2患者的回顾性比较]
Pneumologie. 2023 Jan;77(1):15-20. doi: 10.1055/a-1982-3295. Epub 2023 Jan 23.
6
Characteristics and management of patients with SARS-CoV2 infection admitted to pediatric intensive care units: Data analysis of the Spanish national multicenter registry.因 SARS-CoV2 感染而入住儿科重症监护病房的患者的特征和管理:西班牙全国多中心登记处的数据分析。
Pediatr Pulmonol. 2023 Oct;58(10):2916-2929. doi: 10.1002/ppul.26613. Epub 2023 Jul 26.
7
Severe SARS-Cov2 pneumonia in vaccinated patients: a multicenter cohort study.接种过疫苗的患者中严重的 SARS-CoV-2 肺炎:一项多中心队列研究。
Sci Rep. 2023 Feb 2;13(1):1902. doi: 10.1038/s41598-023-29131-9.
8
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.评估 BIO101 预防 COVID-19 肺炎患者呼吸恶化的疗效和安全性(COVA 研究):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jan 11;22(1):42. doi: 10.1186/s13063-020-04998-5.
9
Clinical factors associated with weaning failure in patients requiring prolonged mechanical ventilation.需要长期机械通气的患者中与撤机失败相关的临床因素。
J Thorac Dis. 2017 Jan;9(1):143-150. doi: 10.21037/jtd.2017.01.14.
10
Incidence of Barotrauma in Patients With COVID-19 Pneumonia During Prolonged Invasive Mechanical Ventilation - A Case-Control Study.COVID-19 肺炎患者在长时间有创机械通气期间发生气压伤的发生率 - 一项病例对照研究。
J Intensive Care Med. 2021 Apr;36(4):477-483. doi: 10.1177/0885066620954364. Epub 2020 Sep 22.

引用本文的文献

1
Predictive Value of Diaphragm and Lung Ultrasonography for Weaning Failure in Critically Ill Patients with Acute Respiratory Failure Due to COVID-19 Pneumonia.膈肌和肺部超声检查对COVID-19肺炎所致急性呼吸衰竭重症患者撤机失败的预测价值
Diagnostics (Basel). 2024 Oct 11;14(20):2263. doi: 10.3390/diagnostics14202263.

本文引用的文献

1
Association between fluid intake and extubation failure in intensive care unit patients with negative fluid balance: a retrospective observational study.液体摄入与负液体平衡重症监护病房患者拔管失败的关联:一项回顾性观察研究。
BMC Anesthesiol. 2022 Jun 1;22(1):170. doi: 10.1186/s12871-022-01708-3.
2
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.拯救脓毒症运动:2021年脓毒症和脓毒性休克国际管理指南
Crit Care Med. 2021 Nov 1;49(11):e1063-e1143. doi: 10.1097/CCM.0000000000005337.
3
The Risk Factors for Weaning Failure of Mechanically Ventilated Patients With COVID-19: A Retrospective Study in National Medical Team Work.新型冠状病毒肺炎机械通气患者撤机失败的危险因素:国家医疗队工作中的一项回顾性研究
Front Med (Lausanne). 2021 Aug 31;8:678157. doi: 10.3389/fmed.2021.678157. eCollection 2021.
4
Management of COPD patients during COVID: difficulties and experiences.COPD 患者在 COVID-19 期间的管理:困难与经验。
Expert Rev Respir Med. 2021 Aug;15(8):1025-1033. doi: 10.1080/17476348.2021.1929176. Epub 2021 May 19.
5
Product of driving pressure and respiratory rate for predicting weaning outcomes.驱动压与呼吸频率的乘积用于预测撤机结果。
J Int Med Res. 2021 May;49(5):3000605211010045. doi: 10.1177/03000605211010045.
6
Dantrolene repurposed to treat sepsis or septic shock and COVID-19 patients.丹曲林钠被重新用于治疗脓毒症或感染性休克及 COVID-19 患者。
Eur Rev Med Pharmacol Sci. 2021 Apr;25(7):3136-3144. doi: 10.26355/eurrev_202104_25569.
7
Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study.比较 COVID-19 和季节性流感的特征、发病率和死亡率:一项全国性、基于人群的回顾性队列研究。
Lancet Respir Med. 2021 Mar;9(3):251-259. doi: 10.1016/S2213-2600(20)30527-0. Epub 2020 Dec 17.
8
Incidence of Barotrauma in Patients With COVID-19 Pneumonia During Prolonged Invasive Mechanical Ventilation - A Case-Control Study.COVID-19 肺炎患者在长时间有创机械通气期间发生气压伤的发生率 - 一项病例对照研究。
J Intensive Care Med. 2021 Apr;36(4):477-483. doi: 10.1177/0885066620954364. Epub 2020 Sep 22.
9
COVID-19 and COPD.新型冠状病毒肺炎(COVID-19)与慢性阻塞性肺疾病(COPD)。
Eur Respir J. 2020 Aug 13;56(2). doi: 10.1183/13993003.02108-2020. Print 2020 Aug.
10
Timing of Intubation and Mortality Among Critically Ill Coronavirus Disease 2019 Patients: A Single-Center Cohort Study.新冠肺炎危重症患者气管插管时机与死亡率:一项单中心队列研究。
Crit Care Med. 2020 Nov;48(11):e1045-e1053. doi: 10.1097/CCM.0000000000004600.

新型冠状病毒肺炎患者撤机失败的危险因素

Risk Factors for Weaning Failure in COVID-19 Patients.

作者信息

Gerovasileiou Effrosyni, Menis Apostolis-Alkiviadis, Gavriilidis George, Magira Eleni, Temperikidis Prodromos, Papoti Sofia, Karavidas Nikitas, Spanos Michael, Zakynthinos Epaminondas, Makris Demosthenes

机构信息

University Hospital of Larissa, Larissa, Greece.

G. Papanikolaou Hospital, Thessaloniki, Greece.

出版信息

J Crit Care Med (Targu Mures). 2023 Jul 31;9(3):170-177. doi: 10.2478/jccm-2023-0021. eCollection 2023 Jul.

DOI:10.2478/jccm-2023-0021
PMID:37588182
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10425926/
Abstract

BACKGROUND

Data on risk factors associated with mechanical ventilation (MV) weaning failure among SARS-CoV2 ARDS patients is limited. We aimed to determine clinical characteristics associated with weaning outcome in SARS-CoV2 ARDS patients under MV.

OBJECTIVES

To determine potential risk factors for weaning outcome in patients with SARS-CoV2 ARDS.

METHODS

A retrospective observational study was conducted in the ICUs of four Greek hospitals via review of the electronic medical record for the period 2020-2021. All consecutive adult patients were screened and were included if they fulfilled the following criteria: a) age equal or above 18 years, b) need for MV for more than 48 hours and c) diagnosis of ARDS due to SARS-CoV2 pneumonia or primary or secondary ARDS of other aetiologies. Patient demographic and clinical characteristics were recorded for the first 28 days following ICU admission. The primary outcome was weaning success defined as spontaneous ventilation for more than 48 hours.

RESULTS

A hundred and fifty eight patients were included; 96 SARS-CoV2 ARDS patients. SOFA score, Chronic Obstructive Pulmonary Disease (COPD) and shock were independently associated with the weaning outcome OR(95% CI), 0.86 (0.73-0.99), 0.27 (0.08-0.89) and 0.30 (0.14-0.61), respectively]. When we analysed data from SARS-CoV2 ARDS patients separately, COPD [0.18 (0.03-0.96)] and shock [0.33(0.12 - 0.86)] were independently associated with the weaning outcome.

CONCLUSIONS

The presence of COPD and shock are potential risk factors for adverse weaning outcome in SARS-CoV2 ARDS patients.

摘要

背景

关于严重急性呼吸综合征冠状病毒2型(SARS-CoV2)所致急性呼吸窘迫综合征(ARDS)患者机械通气(MV)撤机失败相关危险因素的数据有限。我们旨在确定MV支持下SARS-CoV2 ARDS患者撤机结局的临床特征。

目的

确定SARS-CoV2 ARDS患者撤机结局的潜在危险因素。

方法

通过回顾2020年至2021年期间四家希腊医院重症监护病房(ICU)的电子病历,进行了一项回顾性观察研究。对所有连续的成年患者进行筛查,符合以下标准者纳入研究:a)年龄18岁及以上;b)需要MV支持超过48小时;c)因SARS-CoV2肺炎或其他病因的原发性或继发性ARDS而诊断为ARDS。记录ICU入院后前28天患者的人口统计学和临床特征。主要结局为撤机成功,定义为自主通气超过48小时。

结果

共纳入158例患者;其中96例为SARS-CoV2 ARDS患者。序贯器官衰竭评估(SOFA)评分、慢性阻塞性肺疾病(COPD)和休克与撤机结局独立相关[比值比(95%置信区间)分别为0.86(0.73 - 0.99)、0.27(0.08 - 0.89)和0.30(0.14 - 0.61)]。当我们单独分析SARS-CoV2 ARDS患者的数据时,COPD[0.18(0.03 - 0.96)]和休克[0.33(0.12 - 0.86)]与撤机结局独立相关。

结论

COPD和休克的存在是SARS-CoV2 ARDS患者撤机不良结局的潜在危险因素。